Clinical trial
Prospective, Randomized, Multi-Center Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease With the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
NCT02701543 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized, Multi-Center Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease With the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
- Lead sponsor
- University of Leipzig
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2015
- Completion date
- December 31, 2023
- Enrollment
- 414 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral artery disease